Purdue Pharma Cuts More Than Half of U.S. Sales Staff Amid Opioid Crisis Post author:Sam Post published:February 12, 2018 Post category:BioPharma That announcement is a big change in the way Purdue has aggressively marketed OxyContin in the past. Source: BioSpace You Might Also Like SI-BONE Announces Utah's Public Employees Health Plan (PEHP) Establishes Coverage For The Ifuse Procedure For Minimally Invasive SI Joint Fusion October 8, 2017 INC Research Appoints And To Board Of Directors March 2, 2017 FDA Approves 23andMe’s Direct-to-Consumer Genetic Test for Cancer March 6, 2018
SI-BONE Announces Utah's Public Employees Health Plan (PEHP) Establishes Coverage For The Ifuse Procedure For Minimally Invasive SI Joint Fusion October 8, 2017